Probiotics are live microorganisms taken to improve digestive health, support immune function, and maintain a balanced gut environment. They work by adding beneficial bacteria to the trillions of microorganisms already living in your digestive tract, where they help crowd out harmful bacteria, reduce inflammation, and produce compounds your body uses for everything from digestion to mood regulation. Most probiotic supplements contain between 1 and 10 billion colony-forming units (CFU) per dose, though the right amount depends entirely on what you’re using them for.
Preventing and Treating Diarrhea
The strongest evidence for probiotics is in preventing diarrhea caused by antibiotics. Antibiotics kill harmful bacteria, but they also wipe out beneficial ones, which can leave you with loose stools or worse. A meta-analysis of 63 trials involving nearly 12,000 people found that taking probiotics alongside antibiotics significantly reduced the risk of antibiotic-associated diarrhea. In children, the effect was even more pronounced: one trial found that kids given a probiotic yeast had diarrhea lasting an average of 2.3 days compared to 9 days in the control group.
For children with acute infectious diarrhea, specific strains have been shown to shorten both the duration and frequency of symptoms, particularly at doses of 10 billion CFU or higher per day. A European pediatric gastroenterology group recommends starting probiotics at the same time as antibiotics, at doses of at least 5 billion CFU daily, to prevent antibiotic-related gut problems in children.
Easing Irritable Bowel Syndrome
Probiotics can help with the bloating, gas, and unpredictable bowel habits that come with IBS, though the results are modest. A meta-analysis of 21 trials found that people taking probiotics were nearly twice as likely to report improvement in overall symptoms compared to those taking a placebo. Quality of life scores also improved. Another analysis of 23 trials put the number needed to treat at 7, meaning roughly one in every seven people who try probiotics for IBS will see meaningful relief.
The challenge is that not every strain works equally well, and the overall quality of IBS research remains low. If you’re trying probiotics for IBS, it’s worth committing to a consistent strain for at least four weeks before deciding whether it’s helping.
Reducing Colds and Respiratory Infections
Regular probiotic use appears to lower your chances of catching a cold or upper respiratory infection. A Cochrane review of 23 trials covering nearly 7,000 people found that probiotics reduced the number of people who got at least one respiratory infection by about 24%. For people who get sick frequently, the effect was larger: a 41% reduction in the likelihood of having three or more infections. When people did get sick, their symptoms lasted about 1.2 days shorter on average, and they were 42% less likely to need antibiotics.
Most of these studies used one or two bacterial strains taken daily for at least three months. The benefits didn’t come with additional side effects, meaning probiotics were no more likely to cause problems than a placebo.
The Gut-Brain Connection
Your gut and brain communicate constantly through the vagus nerve, a long nerve running from your brainstem to your abdomen. Gut bacteria can influence this pathway directly. They also produce or regulate neurotransmitters like serotonin, dopamine, and GABA, all of which play central roles in mood, anxiety, and stress response.
Certain probiotic strains have been shown in animal and early human studies to reduce stress hormones and behaviors linked to depression and anxiety. One strain reduced depressive behaviors by modulating dopamine and serotonin levels in the brain. Another lowered the body’s stress hormone response. Critically, some of these effects disappeared when the vagus nerve was severed in animal models, confirming that the nerve serves as a direct communication line between gut bacteria and the brain.
This field is still young, and most of the strongest findings come from animal research. But the biological pathways are real: gut bacteria influence inflammation levels, stress hormone production, and a growth factor called BDNF that supports brain cell survival and plasticity.
How Different Strains Work
Not all probiotics do the same thing. The two most common groups in supplements are Lactobacillus and Bifidobacterium, and they have distinct roles in the gut.
- Lactobacillus strains tend to stimulate the arm of the immune system that fights infections directly. They promote gut health primarily by inhibiting harmful bacteria linked to digestive infections and certain cancers. These strains produce lactic acid, which lowers the pH in your gut and makes it harder for pathogens to thrive.
- Bifidobacterium strains lean more toward anti-inflammatory effects. They help calm overactive immune responses and have shown particular promise in mood-related research, with certain strains linked to reduced stress and improved memory in studies.
Because effects are strain-specific, a product that helps with antibiotic-associated diarrhea won’t necessarily do anything for anxiety or bloating. The World Gastroenterology Organisation recommends choosing strains, doses, and durations that have actually been tested for the condition you’re trying to address.
Taking Probiotics With Food
Stomach acid is the biggest obstacle between a probiotic capsule and your intestines, where the bacteria need to arrive alive. Research shows that the presence of simple sugars dramatically improves bacterial survival in acidic conditions. In lab simulations of stomach acid at very low pH, the presence of glucose improved survival of Lactobacillus rhamnosus GG by up to a millionfold. The sugar gives bacteria the energy they need to pump acid out of their cells and stay alive during the roughly 90 minutes of gastric transit.
In practical terms, this means taking your probiotic with a meal or snack that contains some carbohydrates, rather than on a completely empty stomach, gives the bacteria a better chance of reaching your gut intact.
Higher CFU Counts Are Not Always Better
Probiotic labels range from 1 billion to 50 billion CFU or more, and it’s natural to assume more is better. That’s not what the evidence shows. The NIH notes that higher CFU products are not necessarily more effective than lower-count ones. What matters more is whether the specific strain has been studied at the dose listed on the label for the condition you care about.
For preventing antibiotic-associated diarrhea in children, doses around 10 to 20 billion CFU daily have shown the strongest results. For general digestive maintenance, products in the 1 to 10 billion range are typical in clinical trials. There are no formal dosage recommendations for healthy people using probiotics for general wellness.
Prebiotics and Postbiotics
Probiotics are part of a broader ecosystem of supplements. Prebiotics are food for the bacteria already living in your gut. They’re defined as substrates selectively used by beneficial microorganisms to produce a health benefit. In practice, these are specific types of fiber found in foods like garlic, onions, bananas, and asparagus, or sold as supplements.
Postbiotics are a newer category: preparations of non-living microorganisms or their components that still provide health benefits. Unlike probiotics, they don’t need to be alive. This distinction matters because postbiotics are more shelf-stable and may be safer for people who can’t tolerate live bacteria.
Who Should Be Cautious
For healthy people, probiotics are safe. Side effects in clinical trials occur at the same rate as placebo. But for certain groups, live bacteria entering the body carry real risks, including serious infections like sepsis, endocarditis, and abscesses. These complications are rare but have been documented in people who are immunocompromised (organ transplant recipients, people undergoing chemotherapy, those with HIV/AIDS or leukemia), critically or chronically ill patients, premature infants and newborns with immature immune systems, and people with central intravenous lines or receiving IV nutrition.
Norway issued a national warning in 2009 against probiotic use in seriously ill patients, including those already being treated for the very conditions probiotics are sometimes recommended for, like antibiotic-associated diarrhea and C. difficile infection. The increased rate of sepsis in neonates compared to older children and adults suggests that immune immaturity is a key risk factor. For conditions like ulcerative colitis, the 2025 guidelines from the American College of Gastroenterology state there is insufficient evidence to recommend probiotics as primary therapy for either achieving or maintaining remission.